Copyright Reports & Markets. All rights reserved.

Global Orthobiologic Technology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Orthobiologic Technology
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Orthobiologic Technology by Type
    • 1.3.1 Overview: Global Orthobiologic Technology Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Orthobiologic Technology Consumption Value Market Share by Type in 2022
    • 1.3.3 Autologous
    • 1.3.4 Allogenic
  • 1.4 Global Orthobiologic Technology Market by Application
    • 1.4.1 Overview: Global Orthobiologic Technology Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals
    • 1.4.3 Ambulatory Surgical Centres
    • 1.4.4 Orthopaedics Clinics
  • 1.5 Global Orthobiologic Technology Market Size & Forecast
  • 1.6 Global Orthobiologic Technology Market Size and Forecast by Region
    • 1.6.1 Global Orthobiologic Technology Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Orthobiologic Technology Market Size by Region, (2018-2029)
    • 1.6.3 North America Orthobiologic Technology Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Orthobiologic Technology Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Orthobiologic Technology Market Size and Prospect (2018-2029)
    • 1.6.6 South America Orthobiologic Technology Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Orthobiologic Technology Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Orthobiologic Technology Product and Solutions
    • 2.1.4 Medtronic Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Medtronic Recent Developments and Future Plans
  • 2.2 NuVasive, Inc.
    • 2.2.1 NuVasive, Inc. Details
    • 2.2.2 NuVasive, Inc. Major Business
    • 2.2.3 NuVasive, Inc. Orthobiologic Technology Product and Solutions
    • 2.2.4 NuVasive, Inc. Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 NuVasive, Inc. Recent Developments and Future Plans
  • 2.3 Stryker Corporation
    • 2.3.1 Stryker Corporation Details
    • 2.3.2 Stryker Corporation Major Business
    • 2.3.3 Stryker Corporation Orthobiologic Technology Product and Solutions
    • 2.3.4 Stryker Corporation Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Stryker Corporation Recent Developments and Future Plans
  • 2.4 Zimmer Biomet Holdings
    • 2.4.1 Zimmer Biomet Holdings Details
    • 2.4.2 Zimmer Biomet Holdings Major Business
    • 2.4.3 Zimmer Biomet Holdings Orthobiologic Technology Product and Solutions
    • 2.4.4 Zimmer Biomet Holdings Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Zimmer Biomet Holdings Recent Developments and Future Plans
  • 2.5 Orthofix International N.V.
    • 2.5.1 Orthofix International N.V. Details
    • 2.5.2 Orthofix International N.V. Major Business
    • 2.5.3 Orthofix International N.V. Orthobiologic Technology Product and Solutions
    • 2.5.4 Orthofix International N.V. Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Orthofix International N.V. Recent Developments and Future Plans
  • 2.6 Anika Therapeutics, Inc.
    • 2.6.1 Anika Therapeutics, Inc. Details
    • 2.6.2 Anika Therapeutics, Inc. Major Business
    • 2.6.3 Anika Therapeutics, Inc. Orthobiologic Technology Product and Solutions
    • 2.6.4 Anika Therapeutics, Inc. Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Anika Therapeutics, Inc. Recent Developments and Future Plans
  • 2.7 DePuy Synthes (Johnson & Johnson)
    • 2.7.1 DePuy Synthes (Johnson & Johnson) Details
    • 2.7.2 DePuy Synthes (Johnson & Johnson) Major Business
    • 2.7.3 DePuy Synthes (Johnson & Johnson) Orthobiologic Technology Product and Solutions
    • 2.7.4 DePuy Synthes (Johnson & Johnson) Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 DePuy Synthes (Johnson & Johnson) Recent Developments and Future Plans
  • 2.8 Bioventus
    • 2.8.1 Bioventus Details
    • 2.8.2 Bioventus Major Business
    • 2.8.3 Bioventus Orthobiologic Technology Product and Solutions
    • 2.8.4 Bioventus Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Bioventus Recent Developments and Future Plans
  • 2.9 Arthrex, Inc.
    • 2.9.1 Arthrex, Inc. Details
    • 2.9.2 Arthrex, Inc. Major Business
    • 2.9.3 Arthrex, Inc. Orthobiologic Technology Product and Solutions
    • 2.9.4 Arthrex, Inc. Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Arthrex, Inc. Recent Developments and Future Plans
  • 2.10 SeaSpine Holdings Corporation
    • 2.10.1 SeaSpine Holdings Corporation Details
    • 2.10.2 SeaSpine Holdings Corporation Major Business
    • 2.10.3 SeaSpine Holdings Corporation Orthobiologic Technology Product and Solutions
    • 2.10.4 SeaSpine Holdings Corporation Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 SeaSpine Holdings Corporation Recent Developments and Future Plans
  • 2.11 Sanofi-Aventis (Sanofi SA)
    • 2.11.1 Sanofi-Aventis (Sanofi SA) Details
    • 2.11.2 Sanofi-Aventis (Sanofi SA) Major Business
    • 2.11.3 Sanofi-Aventis (Sanofi SA) Orthobiologic Technology Product and Solutions
    • 2.11.4 Sanofi-Aventis (Sanofi SA) Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Sanofi-Aventis (Sanofi SA) Recent Developments and Future Plans
  • 2.12 Djo Global, Inc.
    • 2.12.1 Djo Global, Inc. Details
    • 2.12.2 Djo Global, Inc. Major Business
    • 2.12.3 Djo Global, Inc. Orthobiologic Technology Product and Solutions
    • 2.12.4 Djo Global, Inc. Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Djo Global, Inc. Recent Developments and Future Plans
  • 2.13 Seikagaku Corporation
    • 2.13.1 Seikagaku Corporation Details
    • 2.13.2 Seikagaku Corporation Major Business
    • 2.13.3 Seikagaku Corporation Orthobiologic Technology Product and Solutions
    • 2.13.4 Seikagaku Corporation Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Seikagaku Corporation Recent Developments and Future Plans
  • 2.14 RTI Surgical, Inc.
    • 2.14.1 RTI Surgical, Inc. Details
    • 2.14.2 RTI Surgical, Inc. Major Business
    • 2.14.3 RTI Surgical, Inc. Orthobiologic Technology Product and Solutions
    • 2.14.4 RTI Surgical, Inc. Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 RTI Surgical, Inc. Recent Developments and Future Plans
  • 2.15 Heraeus Holding GmbH
    • 2.15.1 Heraeus Holding GmbH Details
    • 2.15.2 Heraeus Holding GmbH Major Business
    • 2.15.3 Heraeus Holding GmbH Orthobiologic Technology Product and Solutions
    • 2.15.4 Heraeus Holding GmbH Orthobiologic Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Heraeus Holding GmbH Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Orthobiologic Technology Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Orthobiologic Technology by Company Revenue
    • 3.2.2 Top 3 Orthobiologic Technology Players Market Share in 2022
    • 3.2.3 Top 6 Orthobiologic Technology Players Market Share in 2022
  • 3.3 Orthobiologic Technology Market: Overall Company Footprint Analysis
    • 3.3.1 Orthobiologic Technology Market: Region Footprint
    • 3.3.2 Orthobiologic Technology Market: Company Product Type Footprint
    • 3.3.3 Orthobiologic Technology Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Orthobiologic Technology Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Orthobiologic Technology Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Orthobiologic Technology Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Orthobiologic Technology Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Orthobiologic Technology Consumption Value by Type (2018-2029)
  • 6.2 North America Orthobiologic Technology Consumption Value by Application (2018-2029)
  • 6.3 North America Orthobiologic Technology Market Size by Country
    • 6.3.1 North America Orthobiologic Technology Consumption Value by Country (2018-2029)
    • 6.3.2 United States Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Orthobiologic Technology Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Orthobiologic Technology Consumption Value by Type (2018-2029)
  • 7.2 Europe Orthobiologic Technology Consumption Value by Application (2018-2029)
  • 7.3 Europe Orthobiologic Technology Market Size by Country
    • 7.3.1 Europe Orthobiologic Technology Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 7.3.3 France Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Orthobiologic Technology Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Orthobiologic Technology Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Orthobiologic Technology Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Orthobiologic Technology Market Size by Region
    • 8.3.1 Asia-Pacific Orthobiologic Technology Consumption Value by Region (2018-2029)
    • 8.3.2 China Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 8.3.5 India Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Orthobiologic Technology Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Orthobiologic Technology Consumption Value by Type (2018-2029)
  • 9.2 South America Orthobiologic Technology Consumption Value by Application (2018-2029)
  • 9.3 South America Orthobiologic Technology Market Size by Country
    • 9.3.1 South America Orthobiologic Technology Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Orthobiologic Technology Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Orthobiologic Technology Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Orthobiologic Technology Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Orthobiologic Technology Market Size by Country
    • 10.3.1 Middle East & Africa Orthobiologic Technology Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Orthobiologic Technology Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Orthobiologic Technology Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Orthobiologic Technology Market Drivers
  • 11.2 Orthobiologic Technology Market Restraints
  • 11.3 Orthobiologic Technology Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Orthobiologic Technology Industry Chain
  • 12.2 Orthobiologic Technology Upstream Analysis
  • 12.3 Orthobiologic Technology Midstream Analysis
  • 12.4 Orthobiologic Technology Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Orthobiologic Technology market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    The technology using of biological substances to help musculoskeletal injuries heal quicker.
    This report is a detailed and comprehensive analysis for global Orthobiologic Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Orthobiologic Technology market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Orthobiologic Technology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Orthobiologic Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Orthobiologic Technology market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Orthobiologic Technology
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Orthobiologic Technology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings and Orthofix International N.V., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Orthobiologic Technology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Autologous
    Allogenic
    Market segment by Application
    Hospitals
    Ambulatory Surgical Centres
    Orthopaedics Clinics
    Market segment by players, this report covers
    Medtronic
    NuVasive, Inc.
    Stryker Corporation
    Zimmer Biomet Holdings
    Orthofix International N.V.
    Anika Therapeutics, Inc.
    DePuy Synthes (Johnson & Johnson)
    Bioventus
    Arthrex, Inc.
    SeaSpine Holdings Corporation
    Sanofi-Aventis (Sanofi SA)
    Djo Global, Inc.
    Seikagaku Corporation
    RTI Surgical, Inc.
    Heraeus Holding GmbH
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Orthobiologic Technology product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Orthobiologic Technology, with revenue, gross margin and global market share of Orthobiologic Technology from 2018 to 2023.
    Chapter 3, the Orthobiologic Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Orthobiologic Technology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Orthobiologic Technology.
    Chapter 13, to describe Orthobiologic Technology research findings and conclusion.

    Buy now